Disordered gambling: A behavioral addiction

Current Opinion in Neurobiology

Volumn 23, Issue 4, 2013, Pages 655-659

  Clark, Luke ^a   Limbrick Oldfield, Eve H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE;

DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; DRUG TARGETING; FUNCTIONAL NEUROIMAGING; HUMAN; INTERNET ADDICTION; NEUROBIOLOGY; NEUROCHEMISTRY; PATHOLOGICAL GAMBLING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; REWARD;

EID: 84881108159     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2013.01.004     Document Type: Review

References (66)

1. Potenza M.N. Should addictive disorders include non-substance-related conditions?. Addiction 2006, 1013(Suppl 1):142-151.
2. Kuss D.J., Griffiths M. Internet gaming addiction: a systematic review of empirical research. Int J Ment Health Addict 2012, 10:278-296.
3. Weinstein A., Lejoyeux M. Internet addiction or excessive internet use. Am J Drug Alcohol Abuse 2010, 36:277-283.
4. Black D.W., Shaw M., Blum N. Pathological gambling and compulsive buying: do they fall within an obsessive-compulsive spectrum?. Dialogues Clin Neurosci 2010, 12:175-185.
5. Ziauddeen H., Farooqi I.S., Fletcher PC Obesity and the brain: how convincing is the addiction model?. Nat Rev Neurosci 2012, 13:279-286.
6. Lobo D.S., Kennedy J.L. Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction 2009, 104:1454-1465.
7. Lind P.A., Zhu G., Montgomery G.W., Madden P.A.F., Heath A.C., Martin N.G., Slutske W.S. Genome-wide association study of a quantitative disordered gambling trait. Addict Biol 2012, 10.1111/j.1369-1600.2012.00463.x.
8. Meyer G., Schwertfeger J., Exton M.S., Janssen O.E., Knapp W., Stadler M.A., Schedlowski M., Kruger T.H. Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 2004, 29:1272-1280.
9. Dodd M.L., Klos K.J., Bower J.H., Geda Y.E., Josephs K.A., Ahlskog J.E. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005, 62:1377-1381.
10. Molina J.A., Sainz-Artiga M.J., Fraile A., Jimenez-Jimenez F.J., Villanueva C., Orti-Pareja M., Bermejo F. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?. Mov Disord 2000, 15:869-872.
11. Ambermoon P., Carter A., Hall W.D., Dissanayaka N.N., O'Sullivan J.D. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction 2011, 106:283-293.
12. Voon V., Sohr M., Lang A.E., Potenza M.N., Siderowf A.D., Whetteckey J., Weintraub D., Wunderlich G.R., Stacy M. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 2011, 69:986-996.
13. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V., Whetteckey J., Wunderlich G.R., Lang A.E. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595.
14. Fehr C., Yakushev I., Hohmann N., Buchholz H.G., Landvogt C., Deckers H., Eberhardt A., Klager M., Smolka M.N., Scheurich A., et al. Association of low striatal dopamine D2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry 2008, 165:507-514.
15. Martinez D., Broft A., Foltin R.W., Slifstein M., Hwang D.R., Huang Y., Perez A., Frankle W.G., Cooper T., Kleber H.D., et al. Cocaine dependence and D2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 2004, 29:1190-1202.
16. Volkow N.D., Fowler J.S., Wang G-J., Swanson J.M., Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 2007, 64:1575-1579.
17. Boileau I., Payer D., Chugani B., Lobo D., Behzadi A., Rusjan P.M., Houle S., Wilson A.A., Warsh J., Kish S.J., et al. The D(2/3) dopamine receptor in pathological gambling: a PET study with [(11) C]-(+)-propyl-hexahydro-naphtho-oxazin and [(11) C]raclopride. Addiction 2012, 10.1111/add.12066.
18. Clark L., Stokes P.R., Wu K., Michalczuk R., Benecke A., Watson B.J., Egerton A., Piccini P., Nutt D.J., Bowden-Jones H., et al. Striatal dopamine D(2)/D(3) receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage 2012, 63:40-46.
19. Joutsa J., Johansson J., Niemelä S., Ollikainen A., Hirvonen M.M., Piepponen P., Arponen E., Alho H., Voon V., Rinne J.O., et al. Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 2012, 60:1992-1999.
20. Linnet J., Møller A., Peterson E., Gjedde A., Doudet D. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 2011, 106:383-390.
21. O'Sullivan S.S., Wu K., Politis M., Lawrence A.D., Evans A.H., Bose S.K., Djamshidian A., Lees A.J., Piccini P. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011, 134:969-978.
22. 11C] raclopride PET study. Brain 2009, 132:1376-1385.
23. Martinez D., Narendran R., Foltin R.W., Slifstein M., Hwang D.R., Broft A., Huang Y., Cooper T.B., Fischman M.W., Kleber H.D., et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 2007, 164:622-629.
24. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997, 386:830-833.
25. Slutske W.S., Eisen S., True W.R., Lyons M.J., Goldberg J., Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 2000, 57:666-673.
26. Groman S.M., Lee B., Seu E., James A.S., Feiler K., Mandelkern M.A., London E.D., Jentsch J.D. Dysregulation of D(2)-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci 2012, 32:5843-5852.
27. Nader M.A., Morgan D., Gage H.D., Nader S.H., Calhoun T.L., Buchheimer N., Ehrenkaufer R., Mach R.H. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 2006, 9:1050-1056.
28. McElroy S.L., Nelson E.B., Welge J.A., Kaehler L., Keck P.E. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry 2008, 69:433-440.
29. Fong T., Kalechstein A., Bernhard B., Rosenthal R., Rugle L. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav 2008, 89:298-303.
30. Hodgins D.C., Stea J.N., Grant J.E. Gambling disorders. Lancet 2011, 378:1874-1884.
31. Grant J.E., Kim S.W., Hollander E., Potenza M.N. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl) 2008, 200:521-527.
32. Grant J.E., Odlaug B.L., Potenza M.N., Hollander E., Kim S.W. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry 2010, 197:330-331.
33. Petrovic P., Pleger B., Seymour B., Klöppel S., De Martino B., Critchley H., Dolan R.J. Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses. J Neurosci 2008, 28:10509-10516.
34. Pallanti S., Bernardi S., Allen A., Chaplin W., Watner D., DeCaria C.M., Hollander E. Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine. J Psychopharmacol 2010, 24:847-853.
35. Elman I., Becerra L., Tschibelu E., Yamamoto R., George E., Borsook D. Yohimbine-induced amygdala activation in pathological gamblers: a pilot study. PLoS ONE 2012, 7:e31118.
36. van Holst R.J., de Ruiter M.B., van den Brink W., Veltman D.J., Goudriaan A.E. A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. Drug Alcohol Depend 2012, 124:142-148.
37. Chanraud S., Martelli C., Delain F., Kostogianni N., Douaud G., Aubin H.J., Reynaud M., Martinot J.L. Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology 2007, 32:429-438.
38. Ersche K.D., Jones P.S., Williams G.B., Turton A.J., Robbins T.W., Bullmore E.T. Abnormal brain structure implicated in stimulant drug addiction. Science 2012, 335:601-604.
39. Joutsa J., Saunavaara J., Parkkola R., Niemela S., Kaasinen V. Extensive abnormality of brain white matter integrity in pathological gambling. Psychiatry Res 2011, 194:340-346.
40. Yip S.W., Lacadie C., Xu J., Worhunsky P.D., Fulbright R.K., Constable R.T., Potenza M.N. Reduced genual corpus callosal white matter integrity in pathological gambling and its relationship to alcohol abuse or dependence. World J Biol Psychiatry 2011, 10.3109/15622975.2011.568068.
41. Liu X., Hairston J., Schrier M., Fan J. Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev 2011, 35:1219-1236.
42. Reuter J., Raedler T., Rose M., Hand I., Gläscher J., Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005, 8:147-148.
43. de Ruiter M.B., Veltman D.J., Goudriaan A.E., Oosterlaan J., Sjoerds Z., van den Brink W. Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology 2009, 34:1027-1038.
44. van Holst R.J., Veltman D.J., Buchel C., van den Brink W., Goudriaan A.E. Distorted expectancy coding in problem gambling: is the addictive in the anticipation?. Biol Psychiatry 2012, 71:711-748.
45. Balodis I.M., Kober H., Worhunsky P.D., Stevens M.C., Pearlson G.D., Potenza M.N. Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry 2012, 71:749-757.
46. Hommer D.W., Bjork J.M., Gilman J.M. Imaging brain response to reward in addictive disorders. Ann N Y Acad Sci 2011, 1216:50-61.
47. Leyton M., Vezina P. On cue: striatal ups and downs in addictions. Biol Psychiatry 2012, 10.1016/j.biopsych.2012.04.036.
48. Clark L. Decision-making during gambling: an integration of cognitive and psychobiological approaches. Philos Trans R Soc Lond B Biol Sci 2010, 365:319-330.
49. Clark L., Lawrence A.J., Astley-Jones F., Gray N. Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry. Neuron 2009, 61:481-490.
50. Chase H.W., Clark L. Gambling severity predicts midbrain response to near-miss outcomes. J Neurosci 2010, 30:6180-6187.
51. Jessup R.K., O'Doherty J.P. Human dorsal striatal activity during choice discriminates reinforcement learning behavior from the Gambler's Fallacy. J Neurosci 2011, 31:6296-6304.
52. Xue G., Juan C-H., Chang C-F., Lu Z-L., Dong Q. Lateral prefrontal cortex contributes to maladaptive decisions. Proc Natl Acad Sci U S A 2012, 109:4401-4406.
53. Campbell-Meiklejohn D.K., Woolrich M.W., Passingham R.E., Rogers R.D. Knowing when to stop: the brain mechanisms of chasing losses. Biol Psychiatry 2008, 63:293-300.
54. Ligneul R., Sescousse G., Barbalat G., Domenech P., Dreher J.C. Shifted risk preferences in pathological gambling. Psychol Med 2012, 1-10. 10.1017/S0033291712001900.
55. Miedl S.F., Peters J., Büchel C. Altered neural reward representations in pathological gamblers revealed by delay and probability discounting. Arch Gen Psychiatry 2012, 69:177-186.
56. Voon V., Pessiglione M., Brezing C., Gallea C., Fernandez H.H., Dolan R.J., Hallett M. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010, 65:135-142.
57. Tao R., Huang X., Wang J., Zhang H., Zhang Y., Li M. Proposed diagnostic criteria for internet addiction. Addiction 2010, 105:556-564.
58. Zhou Y., Lin F.C., Du Y.S., Qin L.D., Zhao Z.M., Xu J.R., Lei H. Gray matter abnormalities in Internet addiction: a voxel-based morphometry study. Eur J Radiol 2011, 79:92-95.
59. Lin F., Zhou Y., Du Y., Qin L., Zhao Z., Xu J., Lei H. Abnormal white matter integrity in adolescents with internet addiction disorder: a tract-based spatial statistics study. PLoS ONE 2012, 7:e30253.
60. Kim S.H., Baik S-H., Park C.S., Kim S.J., Choi S.W., Kim S.E. Reduced striatal dopamine D2 receptors in people with Internet addiction. Neuroreport 2011, 22:407-411.
61. Erickson K.I., Boot W.R., Basak C., Neider M.B., Prakash R.S., Voss M.W., Graybiel A.M., Simons D.J., Fabiani M., Gratton G., et al. Striatal volume predicts level of video game skill acquisition. Cereb Cortex 2010, 20:2522-2530.
62. Kuhn S., Romanowski A., Schilling C., Lorenz R., Morsen C., Seiferth N., Banaschewski T., Barbot A., Barker G.J., Buchel C., et al. The neural basis of video gaming. Transl Psychiatry 2011, 1:e53.
63. Ko C.H., Liu G.C., Yen J.Y., Chen C.Y., Yen C.F., Chen C.S. Brain correlates of craving for online gaming under cue exposure in subjects with Internet gaming addiction and in remitted subjects. Addict Biol 2011, 10.1111/j.1369-1600.2011.00405.x.
64. Littel M., van den Berg I., Luijten M., van Rooij A.J., Keemink L., Franken I.H. Error processing and response inhibition in excessive computer game players: an event-related potential study. Addict Biol 2012, 17:934-947.
65. Dong G., Zhou H., Zhao X. Impulse inhibition in people with Internet addiction disorder: electrophysiological evidence from a Go/NoGo study. Neurosci Lett 2010, 485:138-142.
66. Griffiths M. Fruit machine gambling: the importance of structural characteristics. J Gambl Stud 1993, 9:101-120.